Benzinga | Jun 16, 2021 06:34AM EDT

Zhongchao Announces Medical Education Services Agreement With AbbVie Subsidiary; Terms Not Disclosed

Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE:ABBV) ("AbbVie"). AbbVie is a research-based global biopharmaceutical company. Pursuant to an agreement to facilitate such cooperation, Zhongchao and AbbVie Shanghai will cooperate in, including but not limited to, developing the medical education contents and producing medical education courses.

Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "AbbVie is one of the top ten global research-oriented biopharmaceutical companies with numerous innovations in the core field of immunology, oncology, neuroscience, and Allergan Aesthetics. In recent years, AbbVie has introduced more and more innovative therapies and drugs to the Chinese market, benefitting Chinese patients. We are honored to cooperate with AbbVie Shanghai to promote the development of medical education."